10-K · February 27, 2026
FMC positions itself as a tier‑one global agrochemicals leader with a concentrated, innovation‑led pipeline (16 actives in discovery; 19 in development) and core products (Rynaxypyr® ≈ $0.8B, Cyazypyr® ≈ $0.4B in 2025).…
Earnings analysis · 10-Q
FMC earnings analysis
Filed April 30, 2026 · Our reading of the company's report
The latest report
FMC Corporation's Q1 2026 results showcased a strong revenue performance of $758.6 million, exceeding estimates, while EPS surpassed expectations with a loss of only -$0.023. The company has maintained its full-year…
Read full summary
FMC Corporation's Q1 2026 results showcased a strong revenue performance of $758.6 million, exceeding estimates, while EPS surpassed expectations with a loss of only -$0.023. The company has maintained its full-year revenue guidance, indicating resilience amid challenging market conditions.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.023
What stood out
-
Q1 2026 Revenue Beat
FMC reported $758.6 million in revenue, surpassing estimates of $738.3 million.
-
EPS Outperformance
The company achieved an EPS of -$0.023, compared to an expected loss of -$0.38, reflecting a positive surprise of 0.94.
-
Recovery in Revenue After Decline
Q1 2026 revenue increased from $791 million in Q1 2025, indicating growth despite prior challenges.
-
Strong Free Cash Flow
FMC reported free cash flow of $378 million in Q4 2025, indicating improved cash generation prior to Q1 2026.
-
Full-Year Revenue Guidance Maintained
Revenue guidance for 2026 remains between $3.60 billion and $3.80 billion, reaffirming management's confidence.
-
Improved Gross Margin
Gross margin for Q1 2026 was reported at 40.0%, showing stability compared to previous quarters.
What to watch
-
Significant Net Loss
FMC continues to experience considerable net losses with an EPS loss of -$0.023 for Q1 2026.
-
Declining Adjusted EBITDA
Operating margin declined to 7.4% in Q1 2025, reflecting ongoing operational challenges.
-
Cash Flow Concerns
Despite a previous solid free cash flow in Q4 2025, Q1 2026 cash flow issues remain a concern with the company's negative performance in recent quarters.
Management's outlook
Full-year guidance maintained despite expected declines in revenue and adjusted earnings.
Earlier filings 4
10-Q · May 2, 2023
FMC reported Q1 revenue of $1,344.3 million, essentially flat year-over-year (down $6.5M vs Q1 2022) while gross margin dollars increased to $581.3 million. Diluted EPS declined to $1.55 from $1.64 a year ago, and…
10-K · February 24, 2023
FMC reports strong top-line momentum in 2022 (revenues grew approximately 15% year‑over‑year and 18% organically) driven by product launches and volume/price gains in North and Latin America, underpinned by a large…
10-Q · November 2, 2022
FMC reported Q3 revenue of $1,377.2 million, up $183.2 million (+15.3%) versus Q3 2021, but gross margin narrowed to $477.5 million from $511.5 million and diluted EPS (net) fell to $0.95 from $1.24. Operating income…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.